| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10036843 | TDSSVTK | 106 | ||
| 10037550 | TDSSVTK | 108 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10036843 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | ||||
| 10037550 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | -3.321928095 | 30620550 | Peptide quantification value was applied to each modification site |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10036843 | TDSSVTK | 106 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | |||
| 10037550 | TDSSVTK | 108 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site |